Dip in PSA Screening Tied to Spike in Metastatic Prostate Cancer in VA System

From 2005 to 2019, prostate-specific antigen (PSA) screening rates decreased, while metastatic prostate cancer rates increased. Veterans Health Administration data showed higher facility-level PSA screening rates were tied to lower metastatic prostate cancer incidence five years later.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ